Pellet hormone therapy carries real safety concerns that major medical organizations want you to know about. The FDA has not approved compounded hormone pellets, and a comprehensive review by the National Academies of Science, Engineering, and Medicine found a lack of rigorous evidence for their safety or effectiveness. That doesn’t automatically mean pellets are dangerous for every person who uses them, but it does mean the safety claims you may have heard from clinics and marketing materials aren’t backed by the kind of clinical evidence that exists for other hormone therapies.
What Medical Organizations Actually Say
The major professional groups that oversee hormone therapy have taken a consistent position: compounded hormone pellets should not be used routinely when FDA-approved alternatives exist. The Endocrine Society states that “little or no scientific evidence exists” to support claims that compounded bioidentical hormones are safer or more effective than FDA-approved options. The American College of Obstetricians and Gynecologists echoes this, recommending that FDA-approved hormone therapies should be the first choice for managing menopausal symptoms.
The National Academies review, delivered to the FDA in 2020, concluded that the widespread use of compounded bioidentical hormones “poses a public health concern.” The safety data that does exist comes mostly from low-quality sources: patient reports, anecdotal claims, and prescriber testimonies rather than controlled clinical trials. The Endocrine Society has also flagged reports of adverse events including endometrial cancer in women using compounded bioidentical therapy, along with studies showing blood hormone levels far above the expected range in women using compounded pellets specifically.
The Marketing Problem
Many compounding pharmacies market pellet therapy using the term “bioidentical” to imply the hormones are natural and therefore safer than conventional options. This framing is misleading. Several FDA-approved hormone therapies already use bioidentical hormones, including micronized progesterone and estradiol. The word “bioidentical” describes the chemical structure of the hormone, not whether it was made by a compounding pharmacy or a regulated manufacturer. The difference is that FDA-approved versions have gone through standardized testing for potency, purity, and clinical safety. Compounded pellets have not, and they face limited federal and state oversight of their quality.
The Pellet-Specific Risk: You Can’t Take It Out
This is the safety concern most unique to pellets compared to other hormone delivery methods. Once a pellet is inserted under your skin, typically in the hip or buttock area, it cannot be retrieved. It dissolves slowly over three to six months, releasing hormones continuously throughout that period.
With creams, patches, or pills, you can stop immediately if you experience side effects or receive a new diagnosis that makes hormone therapy risky. With a pellet, the hormones keep releasing regardless. If you were diagnosed with breast cancer, for example, or developed blood clots, you would still have estrogen or testosterone entering your system for months with no way to shut it off. This is a fundamentally different risk profile than other delivery methods, and it’s one that clinicians have raised repeatedly as a concern.
Procedure Complications
The insertion itself is a minor surgical procedure, but it isn’t complication-free. In a controlled clinical study of testosterone pellet insertions, about 12% of procedures resulted in pellet extrusion, where the pellet works its way back out through the skin before fully dissolving. Bleeding or bruising occurred after roughly 9% of procedures, and infection developed after about 4%. These rates apply per insertion, and since pellets need replacement every three to six months, the cumulative risk adds up over time if you’re on therapy for years.
Dosing Concerns
One of the core problems with compounded pellets is inconsistent dosing. Because these products aren’t manufactured under the same standardized conditions as FDA-approved drugs, the amount of hormone in each pellet can vary. Research presented at a North American Menopause Society meeting found that women using compounded pellets had blood estradiol and testosterone levels well above the anticipated range. Supraphysiologic hormone levels (levels higher than your body would naturally produce) increase the risk of side effects and potentially serious complications.
With testosterone pellets specifically, prolonged exposure to elevated levels can cause acne, hair thinning, deepening of the voice, and other androgenic effects in women. Because the pellet can’t be removed, these effects may continue for months even after the problem is identified.
Who Should Not Use Pellet Therapy
Certain conditions rule out pellet hormone therapy entirely. Testosterone pellets are contraindicated in men with breast cancer or known or suspected prostate cancer. They should not be used during pregnancy, as testosterone exposure can cause serious developmental abnormalities in a female fetus. People with pre-existing heart disease, kidney disease, or liver disease face a risk of serious fluid retention complications. In patients with breast cancer, testosterone therapy can trigger dangerous calcium elevation by stimulating bone breakdown.
FDA-Approved Alternatives
If you’re considering pellet therapy for menopause symptoms or testosterone replacement, it’s worth knowing that FDA-approved options exist for most of the same hormones. Micronized progesterone, estradiol patches, estradiol gels, and FDA-approved testosterone products have all undergone clinical testing with established safety profiles and standardized dosing. These products give you the ability to adjust your dose or stop treatment quickly if needed. The only FDA-approved testosterone pellet on the market, Testopel, is indicated for men only and comes with standardized dosing and labeling requirements that compounded pellets lack.
Compounded preparations do serve a legitimate role for patients who need specific doses or formulations not available commercially, or who have allergies to ingredients in FDA-approved products. But for routine hormone therapy, every major medical organization recommends starting with regulated, FDA-approved options first.